People who are interested in the business of vein treatment may want to know that one of the key people on the Board of Directors for VNUS Medical Technologies has recently stepped down after more than ten years of working with this leading vein treatment product maker. Kathleen D. LaPorte had served on the board of directors since 1997 and was one of the key people involved in the venture capital firm that funded VNUS when it was just a start-up company.
"The Board and management of VNUS would like to sincerely thank Kathy for her many contributions, support, and sound advice as a key member of the Board since the company's early days," said Brian Farley, President and CEO. "As one of the earliest venture capital investors, Kathy's departure from the Board is a normal step in the company's corporate governance since its IPO in October 2004. We expect to continue our past practice of looking to replace venture investors with highly qualified medical device industry experts."
There are currently no plans to replace Kathy's position with a specific individual. Ultimately, she will be replaced by someone who is knowledgeable in vein treatment and who will hopefully be able to help with the forward motion of the company as a developed but growing business.
Question of the Day: Will the leaving of a key board director have any impact on VNUS?
